How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience.

Semanur OzdelHafize Emine SönmezŞengül ÇağlayanÖzlem AkgünTuncay AydınÖzge Babaİlknur BağrulGülçin Otar YenerKübra ÖztürkFerhat DemirDeniz Gezgin YıldırımŞerife Gül KaradağEsra BağlanMustafa ÇakanMukaddes KalyoncuBalahan Bora MakayŞevket Erbil ÜnsalSevcan BakkaloğluMehmet BülbülBetül SözeriNuray Aktay Ayaz

Published in: Pediatric rheumatology online journal (2023)

During 2 years of treatment, 44% of RF-positive polyarthritis patients have inactive disease, and they should be considered as a distinct and important clinical entity requiring aggressive and early treatment.

Keyphrases

end stage renal disease
juvenile idiopathic arthritis
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
clinical trial
disease activity
patient reported outcomes